2018
Sexual Health Education in OB-Gyn Residencies—The Program Directors’ Survey
Worly B, Manriquez M, Stagg A, Blanchard M, Ogburn T, Carson S, Woodland M. Sexual Health Education in OB-Gyn Residencies—The Program Directors’ Survey. International Journal Of Sexual Health 2018, 30: 390-397. DOI: 10.1080/19317611.2018.1527425.Peer-Reviewed Original Research
2005
Comparative genomic hybridization of ectopic pregnancies that fail methotrexate therapy
McKenzie L, El-Zimaity H, Krotz S, Laucirica R, Carson S, Buster J. Comparative genomic hybridization of ectopic pregnancies that fail methotrexate therapy. Fertility And Sterility 2005, 84: 1517-1519. PMID: 16275259, DOI: 10.1016/j.fertnstert.2005.04.064.Peer-Reviewed Original Research
1998
Testosterone Delivery Systems for Women: Present Status and Future Promise
Casson P, Carson S, Buster J. Testosterone Delivery Systems for Women: Present Status and Future Promise. Seminars In Reproductive Medicine 1998, 16: 153-159. PMID: 9711681, DOI: 10.1055/s-2007-1016266.Peer-Reviewed Original ResearchConceptsAndrogen replacement modalitiesTestosterone delivery systemsSurgical menopauseHormone replacementMale hypogonadismMenopausal womenReplacement modalityPhysiologic deliveryNon-reproductive effectsAndrogen levelsT replacementNew delivery systemDelivery systemWomenModalitiesHypogonadismMenopausePatientsReplacementFuture promiseTherapyTestosteroneSteroidsReplacement Dehydroepiandrosterone in the Elderly
Casson P, Carson S, Buster J. Replacement Dehydroepiandrosterone in the Elderly. The Endocrinologist 1998, 8: 187-194. DOI: 10.1097/00019616-199805000-00010.Peer-Reviewed Original ResearchDHEA replacementFuture hormonal therapyEvidence of efficacyPossible beneficial effectsWidespread clinical useDHEA supplementationHormonal therapyAge-related declineIssues of bioavailabilityClinical useBeneficial effectsDehydroepiandrosteroneFountain of youthUnregulated fashionSafety concernsFurther investigationTherapy
1996
Androgen replacement therapy in women: myths and realities.
Casson P, Carson S. Androgen replacement therapy in women: myths and realities. International Journal Of Fertility And Women's Medicine 1996, 41: 412-22. PMID: 8894799.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAndrogen replacementMenopausal womenAndrogen replacement therapyGrowth hormone axisLong-term trialsProlonged therapyAdrenal androgensTestosterone replacementReplacement therapyNatural menopauseHormone axisClinical investigationSide effectsDeficiency statesImmune systemPhysiologic levelsWomenTherapyPotential benefitsPreliminary studyReplacementMenopauseDHEAAndrogensTrials
1991
Low human chorionic somatomammotropin fails to predict spontaneous resolution of unruptured ectopic pregnancies
Carson S, Stovall T, Ling F, Buster J. Low human chorionic somatomammotropin fails to predict spontaneous resolution of unruptured ectopic pregnancies. Fertility And Sterility 1991, 55: 629-630. PMID: 2001763, DOI: 10.1016/s0015-0282(16)54198-3.Peer-Reviewed Original Research
1989
Genetic diagnosis of the preimplantation embryo
Buster J, Carson S. Genetic diagnosis of the preimplantation embryo. American Journal Of Medical Genetics 1989, 34: 211-216. PMID: 2817000, DOI: 10.1002/ajmg.1320340216.Peer-Reviewed Original ResearchRising human chorionic somatomammotropin predicts ectopic pregnancy rupture following methotrexate chemotherapy
Carson S, Stovall T, Umstot E, Andersen R, Ling F, Buster J. Rising human chorionic somatomammotropin predicts ectopic pregnancy rupture following methotrexate chemotherapy. Fertility And Sterility 1989, 51: 593-597. PMID: 2466704, DOI: 10.1016/s0015-0282(16)60605-2.Peer-Reviewed Original ResearchConceptsHuman chorionic somatomammotropinEctopic pregnancyBeta-human chorionic gonadotropinEctopic pregnancy ruptureChorionic somatomammotropinSurgical therapyBeta-hCGMethotrexate chemotherapyMethotrexate treatmentMedical managementTrophoblastic activityHCS levelsChorionic gonadotropinAuthors' seriesPregnancyPatientsSensitive indicatorRuptureChemotherapyGonadotropinMethotrexateProgesteroneTherapyWomen